Yoshio Ikeda Selected Research

Neuronal intranuclear inclusion disease

1/2023	Clinical, radiological, and molecular analyses of neuronal intranuclear inclusion disease with polyglycine inclusions.
8/2016	Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshio Ikeda Research Topics

Disease

15	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 03/2002
15	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2021 - 02/2006
13	Ulcerative Colitis 12/2023 - 11/2002
11	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2015 - 07/2010
9	Inflammation (Inflammations) 04/2023 - 01/2011
9	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 10/2021 - 02/2006
9	Stroke (Strokes) 12/2018 - 01/2011
8	Infarction (Infarctions) 12/2020 - 07/2010
8	Neoplasms (Cancer) 12/2018 - 08/2010
8	Ischemic Stroke 08/2014 - 01/2011
7	Neuroinflammatory Diseases 01/2024 - 01/2011
7	Amyloid Plaque 08/2016 - 01/2011
6	Brain Ischemia (Cerebral Ischemia) 11/2014 - 12/2010
5	Hemorrhage 01/2022 - 08/2014
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2014 - 01/2011
4	Non-alcoholic Fatty Liver Disease 02/2024 - 06/2012
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 02/2006
3	Fibrosis (Cirrhosis) 02/2024 - 12/2011
3	Multiple System Atrophy 01/2024 - 08/2016
3	Thymoma (Thymic Carcinoma) 12/2023 - 05/2020
3	Parkinsonian Disorders (Parkinsonism) 01/2023 - 06/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2016
3	Parkinson Disease (Parkinson's Disease) 01/2023 - 06/2010
3	Myasthenia Gravis 01/2022 - 01/2015
3	Disease Progression 03/2021 - 08/2011
3	Cerebral Hemorrhage 01/2021 - 04/2013
3	Cognitive Dysfunction 01/2020 - 01/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2013
3	Atrial Fibrillation 12/2018 - 08/2014
3	Hypertension (High Blood Pressure) 04/2015 - 03/2011
3	Hypoxia (Hypoxemia) 02/2013 - 07/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 07/2012
2	Encephalitis (Encephalitis, Rasmussen) 12/2023 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 04/2018
2	Chronic Hepatitis C 09/2023 - 01/2003
2	Atrophic Gastritis 05/2023 - 01/2018
2	Amyloidosis 01/2023 - 01/2023
2	Leukoencephalopathies 01/2023 - 03/2015
2	Neuronal intranuclear inclusion disease 01/2023 - 08/2016
2	Dementia (Dementias) 01/2023 - 01/2020
2	Tauopathies 01/2023 - 08/2016
2	Body Weight (Weight, Body) 01/2023 - 11/2018
2	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 01/2022 - 01/2021
2	Siderosis 01/2022 - 01/2021
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2021
2	Pathologic Constriction (Stenosis) 12/2020 - 04/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020 - 01/2018
2	Spasm (Spasms) 09/2019 - 01/2012
2	Cerebellar Ataxia (Dysmetria) 01/2019 - 08/2012
2	Alcoholic Fatty Liver 01/2019 - 08/2017
2	Thrombosis (Thrombus) 09/2018 - 04/2018

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2008
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2011
9	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2011
7	Atorvastatin (Lipitor)FDA Link 03/2013 - 01/2011
6	Neuroprotective AgentsIBA 11/2014 - 01/2011
5	Superoxide Dismutase-1IBA 03/2021 - 10/2008
5	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2014 - 11/2012
4	Nuclear Proteins (Protein, Nuclear)IBA 10/2021 - 08/2012
4	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 12/2014
4	Amlodipine (Norvasc)FDA LinkGeneric 12/2012 - 01/2011
3	Alanine Transaminase (SGPT)IBA 02/2024 - 06/2012
3	CholesterolIBA 02/2024 - 01/2011
3	Protein Kinases (Protein Kinase)IBA 01/2024 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2018
3	SteroidsIBA 11/2023 - 01/2012
3	LipidsIBA 01/2023 - 01/2011
3	C-Reactive ProteinIBA 01/2022 - 04/2013
3	Apolipoproteins E (ApoE)IBA 01/2022 - 03/2013
3	EdaravoneIBA 11/2014 - 04/2013
3	Warfarin (Coumadin)FDA LinkGeneric 08/2014 - 04/2013
3	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2014 - 07/2010
3	AntigensIBA 01/2014 - 11/2002
3	pitavastatin (itavastatin)FDA Link 03/2013 - 01/2011
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2012 - 01/2011
2	CreatinineIBA 02/2024 - 11/2018
2	Triglycerides (Triacylglycerol)IBA 02/2024 - 01/2023
2	Complement System Proteins (Complement)IBA 01/2024 - 01/2020
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2024 - 01/2013
2	Serum AlbuminIBA 10/2023 - 01/2021
2	AlbuminsIBA 04/2023 - 01/2022
2	ORALIT (ORS)IBA 01/2022 - 06/2012
2	Contrast MediaIBA 09/2021 - 01/2012
2	Indicators and Reagents (Reagents)IBA 04/2021 - 12/2020
2	Amyloid beta-PeptidesIBA 01/2021 - 11/2014
2	ApolipoproteinsIBA 01/2021 - 03/2013
2	dapagliflozinIBA 12/2020 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2008
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2019 - 08/2017
2	AnticoagulantsIBA 12/2018 - 11/2018
2	Everolimus FDA Link 09/2018 - 04/2018
2	PlatinumIBA 04/2018 - 07/2011
2	RNA (Ribonucleic Acid)IBA 08/2017 - 08/2009
2	InterferonsIBA 01/2017 - 01/2003
2	Telmisartan (Micardis)FDA Link 04/2015 - 11/2014

Therapy/Procedure

17	Therapeutics 12/2023 - 01/2003
2	Lasers (Laser) 05/2023 - 01/2018
2	Stents 09/2018 - 04/2018
2	Percutaneous Coronary Intervention 11/2015 - 01/2013